9-hydroxy-10,12-octadecadienoic acid has been researched along with Arteriosclerosis in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gniwotta, C; Kühn, H; Morrow, JD; Roberts, LJ | 1 |
Carson, W; Jira, W; Schramm, A; Spiteller, G | 1 |
Carpenter, KL; Garcia-Cruset, S; Guardiola, F; Mitchinson, MJ | 1 |
Jira, W; Spiteller, G | 1 |
Boullier, A; Chang, MK; Glass, CK; Green, SR; Han, KH; Li, A; Quehenberger, O | 1 |
5 other study(ies) available for 9-hydroxy-10,12-octadecadienoic acid and Arteriosclerosis
Article | Year |
---|---|
Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions.
Topics: Aged; Arachidonic Acid; Arteries; Arteriosclerosis; Chromatography, High Pressure Liquid; Dinoprost; Female; Humans; Linoleic Acid; Linoleic Acids; Linoleic Acids, Conjugated; Lipid Peroxidation; Lipoproteins, LDL; Male; Middle Aged; Oxidation-Reduction; Umbilical Veins | 1997 |
Strong increase in hydroxy fatty acids derived from linoleic acid in human low density lipoproteins of atherosclerotic patients.
Topics: Adult; Arteriosclerosis; Female; Humans; Linoleic Acids; Linoleic Acids, Conjugated; Lipid Peroxides; Lipoproteins, LDL; Male; Middle Aged; Ultrasonography | 1998 |
Oxysterols in cap and core of human advanced atherosclerotic lesions.
Topics: Aged; Aged, 80 and over; Arteriosclerosis; Cholesterol; Chromatography, Gas; Fatty Acids; Humans; Hydroxycholesterols; Linoleic Acids; Linoleic Acids, Conjugated; Lipid Metabolism; Lipids; Male; Mass Spectrometry | 1999 |
Dramatic increase of linoleic acid peroxidation products by aging, atherosclerosis, and rheumatoid arthritis.
Topics: Adult; Aged; Aged, 80 and over; Aging; Arteriosclerosis; Arthritis, Rheumatoid; Humans; Linoleic Acid; Linoleic Acids; Linoleic Acids, Conjugated; Lipid Peroxidation; Lipoproteins, LDL; Middle Aged | 1999 |
Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor gamma.
Topics: Animals; Apolipoproteins B; Arteriosclerosis; Cells, Cultured; Down-Regulation; Humans; Linoleic Acid; Linoleic Acids; Linoleic Acids, Conjugated; Lipoproteins, LDL; Mice; Monocytes; Muscle, Smooth, Vascular; Phospholipids; Receptors, CCR2; Receptors, Chemokine; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Signal Transduction; Thiazoles; Thiazolidinediones; Transcription Factors | 2000 |